- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07448233
Application of Mini-Programs in Long-Term Management of Epilepsy in Rural Areas
Research on the Application of Mobile Health Management Mini-Programs in Long-Term Management of Epilepsy in Rural Areas
This project, titled " Research on the Application of Mobile Health Management Mini-Programs in Long-Term Management of Epilepsy in Rural Areas", is led by the First Affiliated Hospital of Air Force Medical University, with Jiang Wen as the principal investigator. It is a prospective, multicenter, cluster-randomized controlled trial involving 1276 patients from eight rural counties in China's northwest region. This study aims to establish a new scheme for improving epilepsy management in rural areas of Northwest China by combining remote mobile health management technology. The primary objective is to evaluate the effectiveness of the remote medical management model using a mobile health management mini-program in improving the self-management ability of rural epilepsy patients; secondary objectives include evaluating the impact of this model on patients' medication adherence, quality of life, health status, and frequency of epileptic seizures. Key components include patient and doctor interfaces for features like medication reminders, and seizure records. The trial runs from December 1, 2025, to November 30, 2028, with primary outcomes measured at 6 and12 months and secondary outcomes assessing medication adherence, quality of life, and safety.
Studieöversikt
Status
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Shaanxi
-
Xi'an, Shaanxi, Kina, 710032
- Department of Neurology, Xijing Hospital, Air Force Medical University
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Patient inclusion criteria:
- Meet the diagnostic criteria for epilepsy established by the International League Against Epilepsy (ILAE).
- Participate in the national rural epilepsy prevention and management project.
- Aged 18 to 64.
- The patient or their primary caregiver possesses a smartphone and is capable of using WeChat.
- Volunteer to participate in the study and sign a written informed consent form.
Patient exclusion criteria:
- Women who plan to become pregnant, are in pregnancy, or are breastfeeding.
- The seizures are caused by clear and reversible triggers.
- Those who have achieved epilepsy remission criteria and currently do not require long-term antiepileptic drug management.
- Severe infections, malignant tumors, severe dysfunction of heart, liver, and kidney functions, or severe physical diseases that the researcher believes will significantly affect epilepsy management, outcome evaluation, or follow-up completion.
- Individuals with severe mental, cognitive, or communication impairments who are unable to cooperate with research and remote management.
- It is expected that the participant will not be able to complete the required follow-up visits, or the investigator deems the participant unsuitable for participation in this study.
- Have participated in any other clinical trials within the past 6 months.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Fyrdubbla
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Standard Rutinmässig Epilepsihantering på Landsbygden
|
|
|
Experimentell: Förbättrad hantering med mobilapp
|
Patient Module: Real-time monitoring, medication reminders, seizure logging, educational resources. Physician Module: remote follow-up, data analytics dashboard. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Epilepsy Self Management Scale Score
Tidsram: 6 and 12 months
|
Evaluation method: The Chinese version of the Epilepsy Self Management Scale was used. This scale includes multiple dimensions (such as drug management, information management, safety management, etc.), and a higher total score indicates stronger self-management ability. |
6 and 12 months
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- XJLL-KY-20252555
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
IPD will not be shared due to privacy constraints, contractual agreements.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .